論文

査読有り 筆頭著者 本文へのリンクあり
2017年9月

Role of ARHGAP24 in ADP Ribosylation Factor 6 (ARF6)-dependent Pseudopod Formation in Human Breast Carcinoma Cells

ANTICANCER RESEARCH
ダウンロード
回数 : 214
  • Shota Uehara
  • ,
  • Koji Saito
  • ,
  • Hisayo Asami
  • ,
  • Yasutaka Ohta

37
9
開始ページ
4837
終了ページ
4844
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.21873/anticanres.11891
出版者・発行元
INT INST ANTICANCER RESEARCH

Background/Aim: The small GTPase ADP ribosylation factor 6 (ARF6) promotes carcinoma cell invasion and metastasis through remodeling of actin cytoskeleton and formation of pseudopod that is regulated by RAC. RHO GTPase activating protein 24 (ARHGAP24), a RAC-specific GTPase activating protein, binds to activated ARF6 and is recruited to the plasma membrane. The aim of the present study was to demonstrate if ARHGAP24 is involved in the ARF6-mediated formation of pseudopods in breast carcinoma cells. Materials and Methods: The formation of pseudopods induced by activated ARF6 was monitored using MDA-MB-231 human breast carcinoma cells. The effect of knockdown of endogenous ARHGAP24 by siRNA was examined. Results: Knockdown of ARHGAP24 in MDA-MB-231 carcinoma cells increased the lifespan of pseudopods to retract, which resulted in increased length of pseudopods induced by activated ARF6. ARHGAP24 required a binding site of ARF6 to achieve ARF6-dependent actin remodeling. Conclusion: ARHGAP24 may regulate pseudopod formation downstream of activated ARF6 in MDA-MB-231 human breast carcinoma cells.

リンク情報
DOI
https://doi.org/10.21873/anticanres.11891
Web of Science
https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000412578200014&DestApp=WOS_CPL
ID情報
  • DOI : 10.21873/anticanres.11891
  • ISSN : 0250-7005
  • eISSN : 1791-7530
  • Web of Science ID : WOS:000412578200014

エクスポート
BibTeX RIS